Endogenous H2S-Triggered In Situ Synthesis of NIR-II-Emitting Nanoprobe for In Vivo Intelligently Lighting Up Colorectal Cancer
Overexpression of endogenous H2S is one of the key characteristic in colon cancer. However, developing endogenous H2S-activated optical probes for specific diagnosis of colorectal cancer is rarely explored. Herein, an in situ H2S-activatable second near-infrared (NIR-II)-emitting nanoprobe based on...
Saved in:
Published in | iScience Vol. 17; pp. 217 - 224 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
26.07.2019
Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 2589-0042 2589-0042 |
DOI | 10.1016/j.isci.2019.06.034 |
Cover
Summary: | Overexpression of endogenous H2S is one of the key characteristic in colon cancer. However, developing endogenous H2S-activated optical probes for specific diagnosis of colorectal cancer is rarely explored. Herein, an in situ H2S-activatable second near-infrared (NIR-II)-emitting nanoprobe based on Ag-chicken egg white (Ag-CEW) complex for intelligently lighting up colorectal cancer was explored. The designed Ag-CEW complex holds efficient NIR-II emission of 1,000–1,400 nm via endogenous H2S-induced in situ chemical reaction to form Ag2S quantum dots (QDs). After reaction, the designed Ag-CEW complex with high photo-stability and biocompatibility was successfully used for NIR-II imaging-guided specific visualization and precise location of colorectal cancer via endogenous H2S activation. Therefore, our findings provide a new route for specifically targeting diagnosis of colon cancer based on the in situ-activatable NIR-II probe.
[Display omitted]
•In situ H2S-activated Ag-CEW probe was designed for specific colon cancer diagnosis•The Ag-CEW probe triggered by H2S presents highly efficient NIR-II emission•The activatable probe can significantly improve the sensitivity of optical imaging•Ag-CEW can completely eliminate the interference signal from liver and spleen
Optical Imaging; Biomolecules; Cancer |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Lead Contact |
ISSN: | 2589-0042 2589-0042 |
DOI: | 10.1016/j.isci.2019.06.034 |